Sino Biopharmaceutical Ltd (SBMFF)
0.43
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Sino Biopharmaceutical Market Cap: 7.828B for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 14, 2024 | 7.828B |
| November 13, 2024 | 7.828B |
| November 12, 2024 | 7.828B |
| November 11, 2024 | 7.828B |
| November 08, 2024 | 7.828B |
| November 07, 2024 | 7.705B |
| November 06, 2024 | 7.705B |
| November 05, 2024 | 8.611B |
| November 04, 2024 | 8.611B |
| November 01, 2024 | 8.611B |
| October 31, 2024 | 8.611B |
| October 30, 2024 | 8.611B |
| October 29, 2024 | 8.611B |
| October 28, 2024 | 8.611B |
| October 25, 2024 | 8.611B |
| October 24, 2024 | 8.611B |
| October 23, 2024 | 8.611B |
| October 22, 2024 | 8.611B |
| October 21, 2024 | 8.611B |
| October 18, 2024 | 8.557B |
| October 17, 2024 | 8.557B |
| October 16, 2024 | 8.557B |
| October 15, 2024 | 8.557B |
| October 14, 2024 | 8.557B |
| October 11, 2024 | 8.557B |
| Date | Value |
|---|---|
| October 10, 2024 | 8.557B |
| October 09, 2024 | 8.557B |
| October 08, 2024 | 8.557B |
| October 07, 2024 | 8.557B |
| October 04, 2024 | 8.557B |
| October 03, 2024 | 8.557B |
| October 02, 2024 | 8.557B |
| October 01, 2024 | 8.557B |
| September 30, 2024 | 8.557B |
| September 27, 2024 | 8.557B |
| September 26, 2024 | 8.557B |
| September 25, 2024 | 7.785B |
| September 24, 2024 | 7.785B |
| September 23, 2024 | 7.785B |
| September 20, 2024 | 7.785B |
| September 19, 2024 | 6.945B |
| September 18, 2024 | 6.945B |
| September 17, 2024 | 6.945B |
| September 16, 2024 | 6.945B |
| September 13, 2024 | 6.945B |
| September 12, 2024 | 6.945B |
| September 11, 2024 | 6.945B |
| September 10, 2024 | 6.945B |
| September 09, 2024 | 6.945B |
| September 06, 2024 | 6.945B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
5.666B
Minimum
Jul 01 2024
28.31B
Maximum
Jul 20 2020
12.94B
Average
10.91B
Median
Jun 29 2022
Market Cap Benchmarks
| HUTCHMED (China) Ltd | 2.862B |
| Pharmaron Beijing Co Ltd | 2.493B |
| Regencell Bioscience Holdings Ltd | 81.98M |
| Prenetics Global Ltd | 58.76M |
| Uni-Bio Science Group Ltd | 24.07M |
Market Cap Related Metrics
| PE Ratio | 25.36 |
| PS Ratio | 2.059 |
| Price to Book Value | 1.732 |
| Price to Free Cash Flow | 11.19 |
| Price | 0.43 |
| Earnings Yield | 3.94% |
| Operating PE Ratio | 9.487 |
| Normalized PE Ratio | 25.74 |